Catalyst Oncology

A variety of therapeutic options are available to patients with recurrent bladder cancer. Recent studies have suggested that the combination of Gemzar® and Platinol® represents the optimal current combination for treatment of advanced or metastatic bladder cancer.  This patient received this combination but more than a yearago. Less is known about how to deal with recurrent metastatic disease. NCCN says: “No standard therapy exists in this setting. Options include single agent therapy with a

Original post:
Taxotere and gemcitabine for bladder cancer